{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:10:29Z","timestamp":1751483429316},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jacl.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T02:54:40Z","timestamp":1434423280000},"page":"647-651","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Apolipoprotein A-V concentration in preterm infants"],"prefix":"10.1016","volume":"9","author":[{"given":"Kazunori","family":"Kayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Fuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeharu","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2015.06.006_bib1","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M106888200","article-title":"Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration","volume":"276","author":"van der Vliet","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2015.06.006_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jacl.2015.06.006_bib3","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","article-title":"ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis","volume":"279","author":"Schaap","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2015.06.006_bib4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0006-291X(02)00808-2","article-title":"Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice","volume":"295","author":"van der Vliet","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacl.2015.06.006_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","article-title":"Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia","volume":"25","author":"Priore Oliva","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.06.006_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2350-11-120","article-title":"Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects","volume":"11","author":"Zhao","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jacl.2015.06.006_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1253\/circj.72.40","article-title":"Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians","volume":"72","author":"Kisfali","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jacl.2015.06.006_bib8","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1194\/jlr.M700011-JLR200","article-title":"APOA5 variants and metabolic syndrome in Caucasians","volume":"48","author":"Grallert","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.06.006_bib9","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.ATV.0000186189.26141.12","article-title":"Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants","volume":"25","author":"Grosskopf","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.06.006_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.atherosclerosis.2008.12.035","article-title":"Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men","volume":"205","author":"Hyun","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2015.06.006_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.metabol.2006.11.002","article-title":"Marked decrease of apolipoprotein A-V in both diabetic and nondiabetic patients\u00a0with end-stage renal disease","volume":"56","author":"Hirano","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2015.06.006_bib12","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.atherosclerosis.2008.11.019","article-title":"Association of plasma apolipoprotein AV with lipid profiles in patients with acute coronary syndrome","volume":"204","author":"Huang","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2015.06.006_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/jp.2008.8","article-title":"Low-density lipoprotein profile changes during the neonatal period","volume":"28","author":"Fujita","year":"2008","journal-title":"J Perinatol"},{"key":"10.1016\/j.jacl.2015.06.006_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.metabol.2009.02.004","article-title":"Very low-density lipoprotein in the cord blood of preterm neonates","volume":"58","author":"Yonezawa","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2015.06.006_bib15","first-page":"624","article-title":"Birth size standards by gestational age for Japanese neonates","volume":"34","author":"Ogawa","year":"1998","journal-title":"Acta Neonatologica Japnonica"},{"key":"10.1016\/j.jacl.2015.06.006_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.ATV.0000155017.60171.88","article-title":"Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography","volume":"25","author":"Okazaki","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.06.006_bib17","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1194\/jlr.D500018-JLR200","article-title":"A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration","volume":"46","author":"Ishihara","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.06.006_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0009-8981(93)90144-S","article-title":"Lipoprotein lipase mass and activity in severe hypertriglyceridemia","volume":"216","author":"Kobayashi","year":"1993","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2015.06.006_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000243407","article-title":"Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns","volume":"60","author":"Averna","year":"1991","journal-title":"Biol Neonate"},{"key":"10.1016\/j.jacl.2015.06.006_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2009.02.024","article-title":"The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome:\u00a0a postprandial study","volume":"206","author":"Cardona","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2015.06.006_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3945\/ajcn.2008.26363","article-title":"Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states","volume":"89","author":"Perez-Martinez","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2015.06.006_bib22","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1210\/jc.2006-1802","article-title":"Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population","volume":"92","author":"Moreno-Luna","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.06.006_bib23","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/ajcn\/80.4.832","article-title":"The -1131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men","volume":"80","author":"Jang","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2015.06.006_bib24","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1194\/jlr.C700002-JLR200","article-title":"Apolipoprotein A-V association with intracellular lipid droplets","volume":"48","author":"Shu","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.06.006_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5551\/jat.E356","article-title":"Apolipoprotein A-V is a potent modulator of HDL and VLDL components in preadolescent children","volume":"16","author":"Abe","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2015.06.006_bib26","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00125-006-0261-0","article-title":"Plasma apolipoprotein A5 and triglycerides in type 2 diabetes","volume":"49","author":"Dallinga-Thie","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2015.06.006_bib27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2796.2008.01987.x","article-title":"Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans","volume":"264","author":"Hahne","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2015.06.006_bib28","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00431-011-1473-y","article-title":"Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates","volume":"170","author":"Gesteiro","year":"2011","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415002615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415002615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T21:40:14Z","timestamp":1566855614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287415002615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1933287415002615"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2015.06.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein A-V concentration in preterm infants","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}